TGF-β is known to be elevated in leiomyomas and acts as a diffusible signaling molecule to alter bone morphogenetic protein 2 (BMP-2), reducing HOXA-10 expression throughout the endometrium [14,15]. The gene discussed is BMP2; the disease is leiomyoma.